We provide evidence that ALK-rearranged NSCLC cells gaining a bona fide mesenchymal phenotype caused by a late, full EMT upon chronic exposure to crizotinib, but not those acquiring only a partial/hybrid E/M transition state, exhibit cross-resistance to multiple-generation ALK–TKIs (Figure 6). Here, ALK is linked to non-small cell lung carcinoma.